Biochemical and Biophysical Research Communications 1984-04-30

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

K Chiba, A Trevor, N Castagnoli

Index: Biochem. Biophys. Res. Commun. 120 , 574, (1984)

Full Text: HTML

Abstract

The neurotoxic chemical MPTP (1-methyl-4-phenyl-1,2,4,5-tetrahydropyridine) is metabolized by rat brain mitochondrial fractions at a rate of 0.91 +/- 0.02 nmoles/mg protein/min. The major metabolite has been identified as the 1-methyl-4- phenylpyridinium species. This biotransformation process is blocked by 10(-7) M deprenyl and pargyline. MPTP itself inhibited the metabolism of benzylamine by brain mitochondrial fractions. These results are discussed in terms of possible bioactivation mechanisms that may be associated with the neurodegenerative properties of MPTP .

Related Compounds

  • MPP+ iodide

Related Articles:

A new dopaminergic nigro-olfactory projection.

2015-09-01

[Acta Neuropathol. 130 , 333-48, (2015)]

The contribution of human OCT1, OCT3, and CYP3A4 to nitidine chloride-induced hepatocellular toxicity.

2014-07-01

[Drug Metab. Dispos. 42(7) , 1227-34, (2014)]

Nucleoside transporters and human organic cation transporter 1 determine the cellular handling of DNA-methyltransferase inhibitors.

2014-08-01

[Br. J. Pharmacol. 171(16) , 3868-80, (2014)]

Vesicular monoamine transporter substrate/inhibitor activity of MPTP/MPP+ derivatives: a structure-activity study.

2008-02-28

[J. Med. Chem. 51 , 760-8, (2008)]

MDR1 transporter protects against paraquat-induced toxicity in human and mouse proximal tubule cells.

2014-10-01

[Toxicol. Sci. 141(2) , 475-83, (2014)]

More Articles...